You Searched For "vaccine maker cyrus poonawalla" and got 16 results
Sort By:
The success story of Cyrus Poonawalla: The vaccine king who is one of the world’s richest billionaires
India’s vaccine king tried to make an affordable Jaguar but chose to go for a ‘product of the masse…
India’s vaccine king Adar Poonawalla will pay $69,000 a week to live on the same neighbourhood as Winston Churchill once did
Poonawalla, who is an alumnus of the University of Westminster, has often referred to London…
India has its eyes and hopes pinned on Adar Poonawalla— the world’s biggest vaccine maker who will be speaking at the Global Trends Festival 2020
If developing a vaccine for COVID-19 virus is the most important thing, the 39-year old Adar Poonaw…
Covishield maker Adar Poonawalla gets dose of his own vaccine
Pune, Jan 16 (IANS) In a huge confidence booster, Serum Institute of India's (SII) Chief Executive …
Cyrus Poonawalla, India’s vaccine king, multiplied his wealth nearly 5 times in a decade
He founded the Serum Institute of India in 1966, with a capital of $12,000. His idea was to de…
US-based biotechnology company Novavax’s COVID-19 shot is 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…
Adar Poonawalla's Serum cuts Covishield vaccine price for state governments to ₹300 a dose after much backlash
In a tweet, Poonawalla called this cut a "philanthropic gesture" that will save crores of rupees…
Serum Institute's second COVID-19 vaccine 'Covavax' likely to be launched in September
Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax …
Centre seeks 300-400 mn vaccine doses, says SII's Poonawalla
Pune, Nov 28 (IANS) The Government of India is looking at getting 300-400 million doses of coronavi…
COVID-19 vaccine will be priced at ₹1,000 and would be available by February for healthcare workers and elderly people, says Serum CEO Adar Poonawalla
"It will probably take two or three years for every Indian to get inoculated, not just because o…
PTI
If 2015 was the ‘Year of the API’, why is there a Remdesivir shortage six years later?
Catchphrases don’t cure, actual drugs do. In fact, since 2015, the year when the government…
WHO confirms existence of fake Covishield vaccines in India; Serum Institute pushes for a booster shot
SII makes India's primary COVID-19 vaccine, locally known as Covishield. Poonawalla also reve…
COVID-19 vaccination for senior citizens to start from March 1 in India — will be free at government hospitals
The Indian government announced today that COVID-19 vaccine doses for senior citizens will be avail…
COVID-19 vaccine tracker: Pfizer says COVID-19 vaccine over 90% effective, Eli Lilly’s antibody drug therapy gets FDA nod for emergency use, Brazil suspends trial of Chinese coronavirus vaccine
It takes a decade or two to design, test, and launch an effective vaccine that can protect billi…
COVID-19 vaccine Covaxin: Bharat Biotech to begin Phase II trials soon
These trials of the BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants,…